Neuropeptides - An overview

Neuropharmacology

Volumn 39, Issue 8, 2000, Pages 1337-1356

  Hökfelt, Tomas ^a   Broberger, Christian ^a   Xu, Zhi Qing David ^a   Sergeyev, Valeriy ^a   Ubink, Ruud ^a   Diez, Margarita ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Coexistence; Feeding; Non peptide antagonists; Non synaptic signalling; Trophic actions

Indexed keywords

NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; OPIATE PEPTIDE; RECEPTOR SUBTYPE;

CENTRAL NERVOUS SYSTEM; GLIA CELL; HUMAN; NERVE INJURY; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; NERVOUS SYSTEM; NEUROPEPTIDES; RECEPTORS, NEUROPEPTIDE;

EID: 0043131153     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00010-1     Document Type: Review

References (208)

1. Acher R., Chauvet J., Chauvet M.T. Man and the chimaera. Ivell R., Russell J.A. Oxytocin: cellular and molecular approaches in medicine and research. Advances in Experimental Medicine and Biology. 1995;615-627 Plenum Press, New York.
2. Advenier C., Rouissi N., Nguyen Q.T., Emonds-Alt X., Breliere J.C., Neliat G., Naline E., Regoli D. Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist. Biochemistry and Biophysics Research Communications. 184:1992;1418-1424.
3. Ames R.S., Sarau H.M., Chambers J.K., Willette R.N., Aiyar N.V., Romanic A.M., Louden C.S., Foley J.J., Sauermelch C.F., Coatney R.W., Ao Z., Disa J., Holmes S.D., Stadel J.M., Martin J.D., Liu W.-S., Glover G.I., Wilson S., McNulty D.E., Ellis C.E., Elshourgagy N.A., Shabon U., Trill J.J., Hay D.W.P., Ohlstein E.H., Bergsma D.J., Douglas S.A. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature. 401:1999;282-286.
4. Appell K.C., Fragale B.J., Loscig J., Singh S., Tomczuk B.E. Antagonists that demonstrate species differences in neurokinin-1 receptors. Molecular Pharmacology. 4:1992;772-778.
5. Baker K.G., Halliday G.M., Hornung J.-P., Geffen L.B., Cotton R.G.H., Törk I. Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus. Neuroscience. 42:1991;757-775.
6. Balasubramaniam A.A. Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides. 18:1997;445-457.
7. Baraban S.C., Hollopeter G., Erickson J.C., Schwartzkroin P.A., Palmiter R.D. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. Journal of Neuroscience. 17:1997;8927-8936.
8. Barrett J.E., Linden M.C., Holloway H.C., Yu M.J., Howbert J.J. Anxiolytic-like effects of the CCK-B antagonists LY262691, LY262684, and LY247348 on punished responding of squirrel monkeys. Society of Neuroscience Abstracts. 17:1991;1063.
9. Belin M.F., Nanopoulos D., Didier D., Aguera M., Steinbusch H., Verhofstad A., Maitre M., Pujol J.F. Immunohistochemical evidence for the presence of gamma-aminobutyric acid and serotonin in one nerve cell. A study on the raphe nuclei of the rat using antibodies to glutamate decarboxylase and serotonin. Brain Research. 275:1983;329-339.
10. Berwin B., Floor E., Martin T.F.J. CAPS (mammalian UNC-31) protein localizes to membranes involved in dense-core vesicle exocytosis. Neuron. 21:1998;137-145.
11. Betancur C., Azzi M., Rostène W. Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy. Trends in Physiological Science. 18:1997;372-386.
12. Bishop G.A. Neuromodulatory effects of cortcotropin releasing factor on cerebellar Purkinje cells: an in vivo study in the cat. Neuroscience. 39:1990;475-492.
13. Bittencourt J.C., Presse F., Arias C., Peto C., Vaughan J., Nahon J.-L., Vale W., Sawchenko P.E. The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. Journal of Comparative Neurology. 319:1992;218-245.
14. Bloom, F.E., Caron, M., Changeux, J.-P., Crabbe, J.C., Crawley, J.N., Frankel, W.N., Morgan, J.I., Nestler, E.J., Paigen, K., Takahashi, J.S., Tonegawa, S. (Eds.) 1998. Knockouts and mutants: genetically dissecting brain and behavior. Brain Research 809, A1-A33.
15. Bock M.G., DiPardo R.M., Evans B.E., Rittle K.E., Whitter W.L., Veber D.E., Anderson P.S., Freidinger R.M. Benzodiazepine gastrin and brain cholecystonkinin receptor ligands: L-365,260. Journal of Medical Chemistry. 32:1989;13-16.
16. Bono de M., Bargmann C.I. Natural variation in a neuropeptide Y receptor homolog modifies social behavior and food response in C. elegans. Cell. 94:1998;679-689.
17. Bradwejn J., Koszycki D., Paradis M., Reece P., Hinton J., Sedman A. Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers. Biology and Psychiatry. 38:1995;742-746.
18. Broberger, C., 1999. Neuropeptide circuitries regulating food and water intake. M.D. Thesis, ISBN 91-628-3650-0. Karolinska Institutet, Stockholm, Sweden.
19. Broberger C., De Lecea L., Sutcliffe J.G., Hökfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide Y and agouti gene-related protein systems. Journal of Comparative Neurology. 402:1998;460-474.
20. Brownstein M.J., Mezey E. Multiple chemical messengers in hypothalamic magnocellular neurons. Hökfelt T., Fuxe K., Pernow B. Progress in Brain Research. 1986;161-168 Elsevier, Amsterdam.
21. Burbach J.P.H., de Wied D. Brain Functions of Neuropeptides. A Current View. 1993;The Parthenon Publishing Group, Carnforth, NY.
22. Calzà L., Giardino L., Hökfelt T. Thyroid hormone-dependent regulation of galanin synthesis in neurons and glial cells after colchicine administration. Neuroendocrinology. 68:1998;428-436.
23. Cao Y.Q., Manthy P.W., Carlson E.J., Gillespie A.-M., Epstein C.J., Basbaum A.I. Primary afferent tachykinins are required to experience moderate to intense pain. Nature. 392:1998;390-394.
24. Carlsson A., Falck B., Hillarp N.-Å. Cellular localization of brain monamines. Acta Physiologica Scandinavia. 196:1962;1-27.
25. Castel M.N., Morino P., Frey P., Terenius L., Hökfelt T. Immunohistochemical evidence for a neurotensin striatonigral pathway in the rat. Neuroscience. 55:1993;833-847.
26. Chang C.P., Pearse R.V.I., O'Connell S., Rosenfeld M.G. Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. Neuron. 11:1993;1187-1195.
27. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., Richardson J.A., Williams S.C., Xiong Y., Kisanuki Y., Fitch T.E., Nakazato M., Hammer R.E., Saper C.B., Yanagisawa M. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 98:1999;437-451.
28. Coulouarn Y., Lihrmann I., Jegou S., Anouar Y., Tostivint H., Beauvillain J.C., Conlon J.M., Bern H.A., Vaudry H. Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proceedings of the National Academy of Science USA. 95:1998;15803-15808.
29. Dahlström A., Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brainstem neurons. Acta Physiologica Scandinavia. 62(Suppl. 232):1964;1-55.
30. Dahlström A., Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system - II. Experimentally induced changes in the intraneuronal amine levels of the bulbospinal neuron systems. Acta Physiologica Scandinavia. 64(Suppl. 247):1965;5-36.
31. Darlison M.G., Richter D. Multiple genes for neuropeptides and their receptors: co-evolution and physiology. Trends in Neuroscience. 22:1999;81-88.
32. DeCamilli P. Co-secretion of multiple signal molecules from endocringe cells via distinct exocytotic pathways. Trends in Pharmacological Science. 12:1991;446-448.
33. De Felipe C., Pinnock R.D., Hunt S.P. Modulation of chemotropism in the developing spinal cord by substance P. Science. 267:1995;899-902.
34. De Felipe C., Herrero J.F., O'Brian J.A., Palmer J.A., Doyle C.A., Smith A.J.H., Laird J.M.A., Belmonte C., Cervero F., Hunt S.P. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature. 392:1998;394-397.
35. De Souza E.B. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology. 20:1995;789-819.
36. Deutch A.Y., Zahm D.S. The current status of neurotensin-dopamine interactions. Annals of the NY Academy of Science. 668:1992;232-252.
37. Diemunsch P., Schoeffler P., Bryssine B., Cheli-Muller L.E., Lees J., McQuade B.A., Spraggs C.F. Antiemetic activity of the NK1 receptor antagonist GR205171 in the treatment of established postoperative nausea and vomiting after major gyneacological surgery. British Journal of Anaesthesia. 82:1999;274-276.
38. Diez M., Koistinaho J., Games D., Hökfelt T. Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F β-amyloid precursor protein. Society of Neuroscience Abstracts. 25:1999;2053.
39. Dionne R.A., Max M.B., Gordon S.M., Parada S., Sang C., Gracely R.H., Sethna N.F., MacLean D.B. The substance P receptor antagonist CP-99,994 reduces acute postoperative pain. Clinical Pharmacology Therapy. 64:1998;562-568.
40. Dooley C.T., Chung N.N., Wilkes B.C., Schiller P.W., Bidlack J.M., Pasternak G.W., Houghten R.A. An all D-amino acid opioid peptide with central analgesic activity from a combinatorial library. Science. 266:1994;2019-2022.
41. Doucette R. Glial influences on axonal growth in the primary olfactory system. Glia. 3:1990;443-449.
42. Douglass J., McKinzie A.A., Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. Journal of Neuroscience. 15:1995;2471-2481.
43. 3H)SNF 8702. Molecular Pharmacology. 41:1992;1089-1095.
44. Du Vigneaud V., Ressler C., Trippett S. The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin. Journal of Biological Chemistry. 205:1953;949-957.
45. Eipper B.A., Mains R.E. Neuropeptide precursors. Adelman G., Smith B.H. Encyclopedia of Neuroscience. 1999;422 Elsevier, Amsterdam.
46. Elias C.F., Saper C.B., Maratos-Filier E., Tritos N.A., Lee C., Kelly J., Tatro J.B., Hoffman G.E., Ollmann M.M., Barsh G.S., Sakurai T., Yanagisawa M., Elmquist J.K. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. Journal of Comparative Neurology. 402:1998;442-459.
47. Elmquist J.K., Elias C.F., Saper C.B. From lesions to leptin: hypothalamic control of food intake and body weight. Neuron. 22:1999;221-232.
48. Erickson J.C., Hollopeter G., Palmiter R.D. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptie Y. Science. 274:1996;1704-1707.
49. Evans B.E., Bock M.G., Rittle K.E., DiPardo R.M., Whitter W.L., Veber D.F., Anderson P.S., Freidinger R.M. Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin. Proceedings of the National Academy of Science USA. 83:1986;4918-4922.
50. Fallon J.H., Ciofi P. Dynorphin-containing neurons. Björklund A., Hökfelt T., Kuhar M.J. Handbook of Neuroanatomy. Neuropeptides in the CNS. Part II. vol. 9:1990;1-130 Elsevier, Amsterdam.
51. Folkers K., Hörig J., Rampold G., Lane P., Rosell S., Björkroth U. Design and synthesis of effective antagonists of substance P. Acta Chemica Scandinavia. 36:1982;389-395.
52. Fontaine B., Klarsfeld A., Hökfelt T., Changeux J.P. Calcitonin gene-related peptide, a peptide present in spinal cord motoneurons, increases the number of acetylcholine receptors in primary cultures of chick myotubes. Neuroscience Letters. 71:1986;59-65.
53. Gall C., Lauterborn J., Isackson P., White J. Seizures, neuropeptides regulation, and mRNA expression in the hippocampus. Progress in Brain Research. 83:1990;371-390.
54. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J.-F., Blanchard J.-C., Laduron P.M. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proceedings of the National Academy of Science USA. 88:1991;10208-10212.
55. Gautvik K.M., de Lecea L., Gautvik V.T., Danielson P.E., Tranque P., Dopazo A., Bloom F.E., Sutcliffe J.G. Overview of the most prevalent hypothalamus-specific mRNAs, as identified by directional tag PCR subtraction. Proceedings of the National Academy of Science USA. 93:1996;8733-8738.
56. Gerfen C.R., Wilson C.J. The basal ganglia. Swanson L.W., Björklund A., Hökfelt T. Handbook of Chemical Neuroanatomy. Integrated Systems of the CNS. Part III. 1996;371-468 Elsevier, Amsterdam.
57. Gozes I., Brenneman D.E. VIP: molecular biology and neurobiological function. Molecular Neurobiology. 3:1990;201-236.
58. Graybiel A.M. Neurotransmitters and neuromodulators in the basal ganglia. Trends in Neuroscience. 13:1990;244-254.
59. Graziadei P.P.C., Monti Graziadei G.A. Neurogenesis and neuron regeneration in the olfactory systems of mammals. I. Morphological aspects of differentiation and structural organization of the olfactory sensory neurons. Journal of Neurocytology. 8:1979;1-18.
60. Gressens P., Hill J.M., Gozes I., Fridkin M., Brenneman D.E. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature. 362:1993;155-158.
61. Gressens P., Paindaveine B., Hill J.M., Evrard P., Brenneman D.E. Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos. European Journal of Neuroscience. 10:1998;1734-1742.
62. Grimmelikhuijzen C.J., Leviev I., Carstensen K. Peptides in the nervous systems of cnidarians: structure, function, and biosynthesis. International Reviews of Cytology. 167:1996;37-89.
63. Gully D., Canton M., Boigegrain R., Jeanjean F., Molimard J.-C., Poncelet M., Gueudet C., Heaulme M., Leyris R., Brouard A., Pelaprat D., Labbé-Jullié C., Mazella J., Soubrié P., Maffrand J.-P., Rostène W., Kitabgi P., Le Fur G. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proceedings of the National Academy of Science USA. 90:1993;65-69.
64. Herbert J. Peptides in the limbic system: neurochemical codes for co-ordinated adaptive responses to behavioural and physiological demand. Progress in Neurobiology. 41:1994;723-791.
65. de Herder W.W., van der Lely A.J., Lamberts S.W. Somatostatin analogue treatment of neuroendocrine tumours. Postgraduate Medical Journal. 72:1996;403-408.
66. Hinuma S., Habata Y., Fujii R., Kawamata Y., Hosoya M., Fukusumi S., Kitada C., Masuo Y., Asano T., Matsumoto H., Sekiguchi M., Kurokawa T., Nishimura O., Onda H., Fujino M. A prolactin-releasing peptide in the brain. Nature. 393:1998;272-276.
67. Hohmann E.L., Elde R.P., Rysavy J.A., Einzig S., Febhard R.L. Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers. Science. 232:1986;868-871.
68. Hökfelt T. Neuropeptides in perspective: The last ten years. Neuron. 7:1991;867-879.
69. Hökfelt T., Fuxe K. On the morphylogy and the neuroendocrine role of the hypothalamic catecholamine neurons. Brain-Endocrine Interaction. Median Eminence: Structure and Function. International Symposium Munich 1971. 1972;181-223 Karger, Basel.
70. Hökfelt T., Zhang X., Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends in Neuroscience. 17:1994;22-30.
71. Hökfelt T., Wiesenfeld-Hallin Z., Villar M., Melander T. Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripherl axotomy. Neuroscience Letters. 83:1987;217-220.
72. Hökfelt T., Xu Z.-Q.D., Shi T.-J., Holmberg K., Zhang X. Galanin in ascending systems: focus on coexistence with 5-hydroxytryptamine and noradrenaline. Annals of the NY Academy of Science. 863:1998;252-263.
73. Hökfelt, T., Arvidsson, U., Cullheim, S., Millhorn, D., Nicholas, A. P., Pieribone, V., Seroogy, K., Ulfhake, B., 2000. Multiple messengers in descending serotonin neurons: localization and functional implications. Journal of Chemistry and Neuroanatomy (in press).
74. Hökfelt, T., Shi, T.-J. S., Gui, J.-G., Meyerson, B., Linderoth, B., Tong, Y.-G., Wang, H.-F., Xu, Z.-Q. D., Ju, G., Grant, G., Zhang, X., 1999. Phenotypic changes induced in dorsal root ganglion neurons by nerve injury. In Kalso, E., McQuay, H.J., Wiesenfeld-Hallin, Z. (Eds) Progress in Pain Research and Management, International Association for the Study of Pain (IASP) Press, Seattle, pp. 145-161.
75. Holsboer F. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. Journal of Psychology Research. 33:1999;181-214.
76. Howbert J.J., Lobb K.L., Brown R.F., Reel J.K., Neel D.A., Mason N.R., Mendelsohn L.G., Hodgkiss J.P., Kelly J.S. A novel series of non-peptide CCK and gastrin antagonists: medicinal chemistry and electrophysiological demonstration of antagonism. Dourish C.T., Cooper S.J., Iversen S.D., Iversen L.L. Multiple Cholecystokinin Receptors in the CNS. 1992;28-37 Oxford University Press, Oxford.
77. Hoyle C.H.V. Neuropeptide families: evolutionary perspectives. Regulatory Peptides. 73:1998;1-33.
78. 2+-dependent exocytosis in the somata of dorsal root ganglion neurons. Neuron. 17:1996;135-145.
79. Hughes J., Boden P., Costall B., Domeney A., Kelly E., Horwell D.C., Hunter J.C., Pinnock R.D., Woodruff G.N. Cholekinoid antagonists, a new class of potent and specific CCK-B ligands having potent anxiolytic activity. Proceedings of the National Academy of Science USA. 87:1990;6728-6732.
80. Ito M. Long-term depression. Annual Reviews in Neuroscience. 12:1989;85-102.
81. Jirikowski G.F., Sanna P.P., Bloom F.E. mRNA coding oxytocin is present in axons of the hypothalamo-neurohypophyseal tract. Proceedings of the National Academy of Science USA. 87:1990;7400-7404.
82. Johnson M.D. Synaptic glutamate release by postnatal rat serotonergic neurons in microculture. Neuron. 12:1994;433-442.
83. Jonas P., Bischofberger J., Sandkühler J. Corelease of two fast neurotransmitters at a central synapse. Science. 281:1998;419-424.
84. Kalra S.P. Appetite and body weight regulation: is it all in the brain? Neuron. 19:1997;227-230.
85. Kaneko T., Akiyama H., Nagatsu I., Mizuno N. Immunohistochemical demonstration of glutaminase in catecholaminergic and serotonergic neurons of rat brain. Brain Research. 507:1990;141-154.
86. Kasakov L., Ellis J., Kirkpatrick K., Milner P., Burnstock G. Direct evidence for concomitant release of noradrenaline, adenosine 5′-triphosphate and neuropeptide Y from sympathetic nerve supplying the guinea-pig vas deferens. Journal of the Autonomic Nervous System. 22:1988;75-82.
87. Kirchmair R., Hogue-Angeletti R., Gutierrez J., Fischer-Colbrie R., Winkler H. Secretoneurin - a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience. 53:1993;359-366.
88. Kitabgi P. Neurotensin modulates dopamine neurotransmission at several levels along brain dopaminergic pathway. Neurochemistry International. 14:1989;111-119.
89. Klein R.S., Fricker L.D. Heterogenous expression of carboxypeptidase E and proenkephalin mRNAs by cultured astrocytes. Brain Research. 569:1992;300-310.
90. Kramer M.S., Cutler N., Feighner J., Shrivastava R., Carman J., Sramek J.J., Reines S.A., Liu G., Snavely D., Wyatt-Knowles E., Hale J.J., Mills S.G., MacCoss M., Swain C.J., Harrison T., Hill R.G., Hefti F., Scolnick E.M., Cascieri M.A., Chicchi G.G., Sadowski S., Williams A.R., Hewson L., Smith D., Carlson E.J., Hargreaves R.J., Rupniak N.M.J. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science. 281:1998;1640-1645.
91. Kreutzberg G.W. Nicholls J.G. Repair and Regeneration of the Nervous System. 1982;57-69 Springer, Berlin.
92. Kristensen P., Judge M.E., Thim L., Ribel U., Christjansen K.N., Wulff B.S., Clausen J.T., Jensen P.B., Madsen O.D., Vrang N., Larsen P.J., Hastrup S. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature. 393:1998;72-76.
93. Kupfermann I. Functional studies of cotransmission. Physiology Review. 71:1991;683-732.
94. Lambert P.D., Couceyro P.R., McGirr K.M., Dall Vechia S.E., Smith Y., Kuhar M.J. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse. 29:1998;293-298.
95. Larhammar D., Söderberg C., Lundell I. Evolution of the neuropeptide Y family and its receptors. Annals of the NY Academy of Science. 839:1998;35-40.
96. de Lecea L., Criado J.R., Prospero-Garcia O., Gautvik K.M., Schweitzer P., Danielson P.E., Dunlop C.L.M., Siggins G.R., Henriksen S.J., Sutcliffe J.G. A cortical neuropeptide with neuronal depressant and sleep-modulating properties. Nature. 381:1996;242-245.
97. de Lecea L., del Rio J.A., Criado J.R., Alcántara S., Morales M., Danielson P.E., Henriksen S.J., Soriano E., Sutcliffe J.G. Cortistatin is expressed in distinct subset of cortical interneurons. Journal of Neuroscience. 17:1997;5868-5880.
98. de Lecea L., Kilduff T.S., Peyron C., Gao Z.-B., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L.F., Gautvik V.T., Bartlett II F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proceedings of the National Academy of Science USA. 95:1998;322-327.
99. Lehmann K.A., Schlusener M., Arabatsis P. Failure of proglumide, a cholecystokinin antagonist, to potentiate clinical morphine analgesia. A randomized double-blind postoperative study using patent-controlled analgesia (PCA). Anesthesia and Analgesia. 68:1989;51-56.
100. Lehman E., Hanze J., Pauschinger M., Ganten D., Lang R.E. Vasopressin mRNA in the neurolobe of the rat pituitary. Neuroscience Letters. 111:1990;170-175.
101. Leibowitz S.F. Brain peptides and obesity: pharmacological treatment. Obesity Research. 3:1995;573S-589S.
102. Letter A.A., Matsuda L.A., Merchant K.M., Gibb J.W., Hanson G.R. Characterization of dopaminergic influence on striatal-nigral neurotensin systems. Brain Research. 422:1987;200-203.
103. Levy A., Lightman S.L., Carter D.A., Murphy D. The origin and regulation of posterior pituitary vasopressin ribonucleic acid in osmotically stimulated rats. Journal of Neuroendocrinology. 2:1990;329-334.
104. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qui X., de Jong P.J., Nishino S., Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 98:1999;365-376.
105. Lundberg J.M. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacology Review. 48:1996;113-178.
106. Lundberg J.M., Hökfelt T. Coexistence of peptides and classical neurotransmitters. TINS. 6:1983;325-333.
107. Marksteiner J., Kirchmair R., Mahata S.K., Mahata M., Fischer-Colbrie R., Hogue-Angeletti R., Saria A., Winkler H. Distribution of secretoneurin, a peptide derived from secretogranin II, in rat brain. An immunocytochemical and radioimmunological study. Neuroscience. 54:1993;923-944.
108. Marksteiner J., Saria A., Kirchmair R., Pycha R., Benesch H., Fischer-Colbrie R., Haring C., Maier H., Ransmay G. Distribution of secretoneurin-like immunoreactivity in comparison with substance P- and enkephalin-like immunoreactivities in various human forebrain regions. European Journal of Neuroscience. 5:1993;1573-11585.
109. Marsh D.J., Hollopeter G., Kafer K.E., Palmiter R.D. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nature. 4:1998;718-721.
110. Massot O., Rousselle J.C., Fillion M.P., Grimaldi B., Cloez-Tayarani I., Fugelli A., Prudhomme N., Seguin L., Rousseau B., Plantefol M., Hen R., Fillion G. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine 1B/1D receptors. Molecular Pharmacology. 50:1996;752-762.
111. McCarthy J.R., Heinrichs S.C., Grigoriadis D.E. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications. Current Pharmacology Design. 5:1999;289-315.
112. McCleane G.J. The cholecystokinin antagonist proglumide enhances the analgesic efficacy of morphine in humans with chronic benign pain. Anesthesia and Analgesia. 87:1998;1117-1120.
113. McGinty J.F., Henrickson S.J., Goldstein A., Terenius L., Bloom F.E. Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations following kainic acid administration and colchicine induced neurotoxicity. Proceedings of the National Academy of Science USA. 80:1983;589.
114. McKenzie J.C. Aterial natriuretic peptide-like immunoreactivity in astrocytes of parenchyma and glia limitans of the canine brain. Journal of Histochemistry and Cytochemistry. 40:1992;1211-1222.
115. Meister B., Hökfelt T. Peptide- and transmitter-containing neurons in the mediobasal hypothalamus and their relation to GABAergic systems: possible roles in control of prolactin and growth hormone secretion. Synapse. 2:1988;585-605.
116. Melner M., Low K.G., Allen R.G., Nielsen C.P., Young S.L., Saneto R.P. The regulation of proenkephalin expression in a distinct population of glial cells. EMBO Journal. 9:1990;791-796.
117. 1 receptor. Nature. 377:1995;532-535.
118. Migaud M., Roques B.P., Durieux C. Evidence for a high affinity uptake for cholecystokinin octapeptide (CCK8) in rat cortical synaptosomes. European Journal of Neuroscience. 7:1995;1074-1079.
119. Miyata M., Okada D., Hashimoto K., Kano M., Ito M. Corticotropin-releasing factor plays a permissive role in cerebellar long-term depression. Neuron. 22:1999;763-775.
120. Mohr E., Zhou A., Thorn N.A., Richter D. Rats with physically disconnected hypothalamo-pituitary tracts no longer contain vasopressin-oxytocin gene transcripts in the posterior pituitary lobe. FEBS Letters. 263:1990;332-336.
121. Morris J.F., Pow D.V., Sokol H.W., Ward A. Dendritic release of peptides from magnocellular neurons in normal rats, Brattleboro rats and mice with hereditary nephrogenic diabetes insipidus. Gross P., Richter D., Robertson G.L. Vasopressin. 1993;171-182 John Libbey Eurotext, Paris.
122. Murphy D., Levy A., Lightman S., Carter D. Vasopressin mRNA in the neural lobe of the pituitary: dramatic accumulation in response to salt-loading. Proceedings of the National Academy of Science USA. 86:1989;9002-9005.
123. Naeilhan P., Hassani H., Canals J.M., Ekstrand A.J., Larefalk Å., Chhajlani V., Arenas E., Gedda K., Svensson L., Thorén P., Ernfors P. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor. Nature Medicine. 5:1999;1188-1193.
124. Navari R.M., Reinhardt R.R., Gralla R.J., Kris M.G., Hesketh P.J., Khojasteh A., Kindler H., Grote T.H., Pendergrass K., Grunberg S.M., Carides A.D., Gertz B.J. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 antiemetic trials group. New England Journal of Medicine. 340:1999;190-195.
125. Nelson L.S., Kim K., Memmott J.E., Li C. FMRFamide-related gene family in the nematode Caenorhabditis elegans. Molecular Brain Research. 58:1998;103-111.
126. Nemeroff C.B. The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia. Psychoneuroendocrinology. 11:1986;15-37.
127. Nemeroff C.B. Psychopharmacology of affective disorders in the 21st century. Biological Psychiatry. 44:1998;517-525.
128. New H.V., Mudge A.W. Calcitonin gene-related peptide regulates muscle acetylcholine receptor synthesis. Nature. 323:1986;809-811.
129. Nicholas A.P., Cuello A.C., Goldstein M., Hökfelt T. Glutamate-like immunoreactivity in medulla oblongata catecholamine/substance P neurons. NeuroReport. 1:1990;235-238.
130. Nicholas A.P., Pieribone V.A., Arvidsson U., Hökfelt T. Serotonin-, substance P- and glutamate/aspartate-like immunoreactivities in medullo-spinal pathways of rat and primate. Neuroscience. 48:1992;545-559.
131. Nielsch V., Bisby M.A., Keen P. Effect of cutting or crushing the rat sciatic nerve on synthesis of substance P by isolated L5 dorsal root ganglia. Neuropeptides. 10:1987;137-145.
132. Nilsson J., von Euler A., Dalsgaard C.J. Stimulation of connective tissue cell growth by substance P and substance K. Nature. 315:1985;61-63.
133. Noguchi K., Senba E., Morita Y., Sato M., Tohyama M. α-CGRP and β-CGRP mRNAs are differentially regulated in the rat spinal cord and dorsal root ganglion. Molecular Brain Research. 7:1990;299-304.
134. O'Malley S.S., Jaffe A.J., Chang G., Schottenfeld R.S., Meyer R.E., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Archives of General Psychiatry. 49:1992;881-887.
135. Okuda-Ashitaka E., Minami T., Tachibana S., Yoshihara Y., Nishiuchi Y., Kimura T., Ito S. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature. 392:1998;286-289.
136. Ollmann M.M., Wilson B.D., Yang Y.-K., Kerns J.A., Chen Y., Gantz I., Barsh G.S. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science. 278:1997;135-138.
137. Otsuka M., Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiology Review. 73:1993;229-308.
138. Ottersen O.P., Storm-Mathisen J., Somogyi P. Colocalization of glycine-like and GABA-like immunoreactivities in Golgi cell terminals in the rat cerebellum: a postembedding light and electron microscopic study. Brain Research. 450:1988;342-353.
139. Palkovits M., Leranth C., Görcs T., Young W.S.I. Corticotropin-releasing factor in the olivocerebellar tract of rats: demonstration by light- and electron-microscopic immunohistochemistry and in situ hybridization. Proceedings of the National Academy of Science USA. 84:1987;3911-3915.
140. Palmiter R.D., Erickson J.C., Hollopeter G., Baraban S.C., Schwartz M.W. Life without neuropeptide Y. Recent Progress in Hormone Research. 53:1998;163-199.
141. Pedrazzini T., Seydoux J., Küstner P., Aubert J.-F., Grouzmann E., Beermann F., Brunner H.-R. Cardiovascular response, feeding behaviour and locomotor activity in mice lacking the NPY Y1 receptor. Nature. 4:1998;722-726.
142. Penny G.R., Afsharpour S., Kitai S.T. The glutamate decarboxylase-, leucine enkephalin-, methionine enkephalin- and substance P-immunoreactive neurons in the neostriatum of the rat and cat: evidence for partial population overlap. Neuroscience. 17:1986;1011-1045.
143. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., Kilduff T.S. Neurons containing hypocretin (orexin) project to multiple neuronal systems. Journal of Neuroscience. 18:1998;9996-10015.
144. Piccioli P., Di Luzio A., Amann R., Schullgoi R., Azim Surani M., Donnerer J., Cattaneo A. Neuroantibodies: ectopic expression of a recombinant anti-substance P antibody in the central nervous system of transgenic mice. Neuron. 15:1995;373-384.
145. Potter E., Sutton S., Donaldson C., Chen R., Perrin M., Lewis K., Sawchenko P.E., Vale W. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proceedings of the National Academy of Science USA. 91:1994;8777-8781.
146. Price D.D., van der Gruen A., Miller J., Rafii A., Price C. Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist. Anesthesia and Analgesia. 64:1985;801-806.
147. Reinscheid R.K., Nothacker H.P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J.J., Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science. 270:1995;792-794.
148. Roques B.P., Noble F. Dual inhibitors of enkephalin-degrading enzymes (neutral endopeptidase 24.11 and aminopeptidase N) as potential new medications in the management of pain and opioid addiction. NIDA Research Monographs. 147:1995;104-145.
149. Sakanaka M., Shibasaki T., Lederis K. Corticotropin releasing factor-like immunoreactivity in the rat brain as revealed by a modified cobalt-glucose oxidase-diaminobenzidine method. Journal of Comparative Neurology. 260:1987;256-298.
150. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richardson J.A., Kozlowski G.P., Wilson S., Arch J.R.S., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.-S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 92:1998;573-585.
151. Sawchenko P.E. Toward a new neurobiology of energy balance, appetite and obesity: the anatomists weigh in. Journal of Comparative Neurology. 402:1998;435-441.
152. Schalling M., Dagerlind Å., Brene S., Petterson R., Kvist S., Brownstein M., Hyman S.E., Mucke L., Goodman H.M., Joh T.H., Goldstein M., Hökfelt T. Localization of mRNA for phenylethanolamine N-methyltransferase (PNMT) using in situ hybridization. Acta Physiologica Scandinavia. 131:1987;631-632.
153. Schoofs L., Veelaert D., Vanden Broeck J., De Loof A. Peptides in the
154. Schwartz J. Neurotransmitters as neurotrophic factors: a new set of functions. International Reviews of Neurobiology. 34:1990;1-23.
155. Schwartz J.P., Simantov R. Developmental expression of proenkephalin mRNA in rat striatum and in striatal cultures. Developments in Brain Research. 40:1988;311-314.
156. Schwartz T.W.U.G., Schambye H.T., Hjorth S.A. Molecular mechanism of action of non-peptide ligands for peptide receptors. Current Pharmacological Design. 1:1995;325-342.
157. Schwarzer C., Sperk G., Samanin R., Rizzi M., Gariboldi M., Vezzani A. Neuropeptides - immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis. Brain Research Review. 22:1996;27-50.
158. Seidah N.G., Chretien M. Eukaryotic protein processing: endoproteolysis of precursor proteins. Current Opinion in Biotechnology. 8:1997;602-607.
159. Sergeyev V., Hökfelt T., Hurd Y. Serotonin and substance P coexist in dorsal raphe neurons of the human brain. NeuroReport. 10:1999;3967-3970.
160. Shehab S.A., Atkinson M.E. Vasoactive intestinal polypeptide (VIP) increases in the spinal cord after peripheral axotomy of the sciatic nerve originate from primary afferent neurons. Brain Research. 372:1986;37-44.
161. Shinoda H., Marin A.M., Schwartz J.P. Developmental expression of the proenkephalin and prosomatostatin genes in cultured cortical and cerebellar astrocytes. Developments in Brain Research. 67:1992;205-210.
162. Shinoda H., Marini A., Cosi C., Schwartz J. Brain region and gene specificity of neuropeptide gene expression. Science. 245:1989;415-417.
163. Shutter J.R., Graham M., Kinsey A.C., Scully S., Lüthy R., Stark K.L. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes and Development. 11:1997;593-602.
164. Siegel J.M. Narcolepsy: a key role for hypocretins (orexins). Cell. 98:1999;409-412.
165. Skofitsch G., Jacobowitz D.M., Zamir N. Immunohistochemical localization of a melanin-concentrating hormone-like peptide in the rat brain. Brain Research Bulletin. 15:1985;635-649.
166. Sneddon P., Westfall D.P. Pharmacological evidence that adenosine triphosphate and noradrenaline are cotransmitters in the guinea-pig vas deferens. Journal of Physiology. 347:1984;561-580.
167. Snider R.M., Constantine J.W., Lowe I.J., Longo K.P., Lebel W.S., Woody H.A., Drozda S.E., Desai M.C., Vinick F.J., Spencer R.W., Hess H.-J. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science. 251:1991;435-437.
168. Spruce B.A., Curtis R., Wilkin G.P., Glover D.M.A. A neuropeptide precursor in cerebellum: proenkephalin exists in subpopulations of both neurons and astrocytes. EMBO Journal. 9:1990;1787-1795.
169. Steine-Martin A., Osborne J.G., Hauser K.F. Co-localization of proenkephalin mRNA using cRNA probes and a cell-type-specific immunocytochemical marker for intact astrocytes in vitro. Journal of Neuroscience Methods. 36:1991;119-126.
170. Steiner D.F. The proprotein convertases. Current Opinion in Chemical Biology. 2:1998;31-39.
171. Strand F. Neuropeptides: Regulators of Physiological Processes. 1999;MIT Press, Cambridge, MA.
172. Strand F.L., Rose K.J., Zuccarelli L.A., Kume J. Neuropeptide hormones as neurotrophic factors. Physiology Review. 71:1991;1017-1037.
173. Südhof T.C. The synaptic vesicle cycle: a cascade of protein-protein interactions. Nature. 375:1995;645-653.
174. Thiele T.E., Marsh D.J., Marie L.S., Bernstein I.L., Palmiter R.D. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature. 396:1998;366-369.
175. Thureson-Klein Å., Klein R.L. Exocytosis from neuronal large dense-cored vesicles. International Review of Cytology. 121:1990;67-126.
176. Timpl P., Spanagel R., Sillaber I., Kresse A., Reul J.M.H.M., Stalla G.K., Blanquet V., Steckler T., Holsboer F., Wurst W. Imparied stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nature Genetics. 19:1998;162-166.
177. Todd A.J., Sullivan A.C. Light microscope study of the coexistence of GABA-like and glycin-like immunoreactivities in the spinal cord of the rat. Journal of Comparative Neurology. 296:1990;496-505.
178. Tohyama M. An overview of the ontogeny of neurotransmitters and neuromodulators in the central nervous system. Björklund A., Hökfelt T., Tohyama M. Handbook of Chemical Neuroanatomy. Ontogeny of Transmitters and Peptides in the CNS, Vol. 10. 1992;647-650 Elsevier, Amsterdam.
179. Ubink R., Halasz N., Zhang X., Dagerlind Å., Hökfelt T. Neuropeptide tyrosine is expressed in ensheating cells around the olfactory nerves in the rat olfactory bulb. Neuroscience. 60:1994;709-726.
180. Vanden Broeck J., Poels J., Simonet G., Dickens L., De Loof A. Identification of G protein-coupled receptors in insect cells. Annals of the NY Academy of Science. 839:1998;123-128.
181. Vaughan J.M., Fischer W.H., Hoeger C., Rivier J., Vale W. Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology. 125:1989;1660-1665.
182. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Rivier J., Sawchenko P.E., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 38:1995;287-292.
183. Verhage M., McMahon H.T., Ghijsen W.E.J.M., Boomsma F., Scholten G., Wiegant V.M., Nicholls D.G. Differential release of amino acids, neuropeptides, and catecholamines from isolated nerve terminals. Neuron. 6:1991;517-524.
184. Vertes Z., Melegh G., Vertes M., Kovacs S. Effect of naloxone and p-met2-pro5-enkephalinamide treatment on the DNA synthesis in the developing rat brain. Life Science. 31:1982;119-126.
185. Vilijn M.-H., Vaysse P.J.-J., Zukin R.S., Kessler J.A. Expression of preproenkephalin mRNA by cultured astrocytes and neurons. Proceedings of the National Academy of Science USA. 85:1988;6551-6555.
186. Volpicelli J.R., Alterman A.I., Hayashida M., O'Brien C.P. Naltrexone in the treatment of alcohol dependence. Archives of General Psychiatry. 49:1992;876-880.
187. Wachi M., Okuda M., Togashi S., Miyashita O., Wakahoi T. Effects of methamphetamine administration on brain neurotensin-like immunoreactivity in rats. Neuroscience Letters. 78:1987;222-226.
188. Wagner J.J., Terman G.W., Chavkin C. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature. 363:1993;451-454.
189. Wahlestedt C. Antisense oligonucleotide strategies in neuropharmacology. Trends in Pharmacological Science. 151:1994;42-46.
190. Wakisaka S., Kajander K.C., Bennett G.J. Increased neuropeptide (NPY)-like immunoreactivity in rat sensory neurons following peripheral axotomy. Neuroscience Letters. 124:1991;200-203.
191. Watson S., Khachaturian H., Akil H., Coy C., Goldstein A. Comparison of the distribution of dynorphin systems and enkephalin systems in brain. Science. 218:1982;1134-1136.
192. Weisskopf M.G., Zalutsky R.A., Nicoll R.A. The opioid peptide dynorphin mediates heterosynapsis depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature. 362:1993;423-427.
193. White D.M. Contribution of nerotrophin-3 to the neuropeptide Y-induced increase in neurite outgrowth of rat dorsal root ganglion cells. Neuroscience. 86:1998;257-263.
194. White D.M., Mansfield K. Vasoactive intestinal polypeptide and neuropeptide Y act indirectly to increase neurite outgrowth of dissociated dorsal root ganglion cells. Neuroscience. 73:1996;881-887.
195. de Wied D. Behavioral pharmacology of neuropeptides related to melanocortins and the neurohypophyseal hormones. European Journal of Pharmacology. 375:1999;1-11.
196. Wiesenfeld-Hallin Z., Bartfai T., Hökfelt T. Galanin in sensory neurons in the spinal cord. Frontiers of Neuroendocrinology. 13:1992;319-343.
197. Woods S.C., Seeley R.J., Porte D.J., Schwartz M.W. Signals that regulate food intake and energy homeostasis. Science. 280:1998;1378-1383.
198. Xu Z.-Q.D., Shi T.-J.S., Hökfelt T. Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and -R2 receptors. Journal of Comparative Neurology. 392:1998;227-252.
199. Xu Z.-Q.D., Zhang X., Pieribone V.A., Grillner S., Hökfelt T. Galanin-5-hydroxytryptamine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors. Neuroscience. 87:1998;79-94.
200. Young W.S.I. In situ hybridization histochemistry. Björklund A., Hökfelt T., Wouterlood F.G., Van den Pol A.N. Handbook of Chemical Neuroanatomy, Vol. 8. 1990;481-512 Elsevier, Amsterdam.
201. Zadina J.E., Hackler L., Ge L.-J., Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature. 386:1997;499-502.
202. Zhang X., Cortés R., Villar M., Morino P., Castel M.-N., Hökfelt T. Evidence for upregulation of galanin synthesis in rat glial cells in vivo after colchicine treatment. Neuroscience Letters. 145:1992;185-188.
203. Zhang X., Dagerlind Å., Elde R.P., Castel M.-N., Broberger C., Wiesenfeld-Hallin Z., Hökfelt T. Marked increase in cholecystokinin B receptor messenger RNA levels in rat dorsal root ganglia after peripheral axotomy. Neuroscience. 57:1993;227-233.
204. Zhang X., Shi T.-J., Holmberg K., Landry M., Huan W., Xiao H., Ju G., Hökfelt T. Expression and regulation of the neuropeptide Y Y2 receptor in sensory and autonomic ganglia. Proceedings of the National Academy of Science USA. 94:1997;729-734.
205. Zhang X., Wiesenfeld-Hallin Z., Hökfelt T. Effect of peripheral axotomy on expression of neuropeptide Y receptor mRNA in rat lumbar dorsal root ganglia. European Journal of Neuroscience. 6:1994;43-57.
206. Zhang Y., Proenca R., Maffei M., Barone M., Leopold L., Friedman J.M. Positional cloning of the mouse obese gene and its human homologue. Nature. 372:1994;425-432.
207. Zigmond R.E., Hyatt-Sachs H., Mohney R.P., Schreiber R.C., Shadiack A.M., Sun Y., Vaccariello S.A. Changes in neuropeptide phenotype after axotomy of adult peripheral neurons and the role of leukemia inhibitory factor. Perspectives in Developmental Neurobiology. 4:1996;75-90.
208. Zimmer A., Zimmer A.M., Baffi J., Usdin T., Reynolds K., Konig M., Palkovits M., Mezey E. Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene. Proceedings of the National Academy of Science USA. 95:1998;2630-2635.